Domestic Sales Agreement Concluded: Stick-on, Chew-on, Chooseable Smoking Cessation Aid (OTC Drug) 'Nicotinell' Begins Sales from Sato Pharmaceutical
NQ Score
100/100
AI Summary (NQ-processed)
Sato Pharmaceutical Co., Ltd. has entered into a domestic sales agreement with Dr. Reddy's Laboratories Ltd. for the smoking cessation aid "Nicotinell." The product series, available in gum and patch forms, will be launched in Japan on April 1, 2026, to help individuals quit smoking by alleviating withdrawal symptoms.
AI analysis data is not yet available.